Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward of Goodwill

The following is a rollforward of the Company’s goodwill by segment ($ in millions):  

	Biotechnology		Life Sciences		Diagnostics		Total
Balance, January 1, 2023	$	22,087	$	8,314	$	6,875	$	37,276
Attributable to 2023 acquisitions	—		3,851		—		3,851
Adjustments due to finalization of purchase price adjustments	2		5		—		7
Foreign currency translation and other	388		51		35		474
Balance, December 31, 2023	22,477		12,221		6,910		41,608
Attributable to 2024 acquisitions	—		305		—		305
Adjustments due to finalization of purchase price allocations	—		(23)		—		(23)
Foreign currency translation and other	(1,040)		(198)		(155)		(1,393)
Balance, December 31, 2024	$	21,437	$	12,305	$	6,755	$	40,497

Schedule of Finite-lived Intangible Assets and Indefinite-lived Intangible Assets by Major Class

The following summarizes the gross carrying value and accumulated amortization for each major category of intangible assets as of December 31 ($ in millions): 

	2024				2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangibles:
Patents and technology	$	14,781	$	(4,641)	$	15,175	$	(3,832)
Customer relationships, trade names and other intangibles	9,972		(4,781)		10,131		(4,303)
Total finite-lived intangibles	24,753		(9,422)		25,306		(8,135)
Indefinite-lived intangibles:
Trademarks and trade names	3,237		—		3,575		—
Total intangibles	$	27,990	$	(9,422)	$	28,881	$	(8,135)